Center for Financial Planning’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68K | Hold |
100
| – | – | ﹤0.01% | 573 |
|
|
2025
Q1 | $1.54K | Hold |
100
| – | – | ﹤0.01% | 607 |
|
|
2024
Q4 | $2.2K | Hold |
100
| – | – | ﹤0.01% | 530 |
|
|
2024
Q3 | $1.8K | Hold |
100
| – | – | ﹤0.01% | 501 |
|
|
2024
Q2 | $1.63K | Hold |
100
| – | – | ﹤0.01% | 506 |
|
|
2024
Q1 | $1.41K | Hold |
100
| – | – | ﹤0.01% | 543 |
|
|
2023
Q4 | $1.04K | Hold |
100
| – | – | ﹤0.01% | 482 |
|
|
2023
Q3 | $1.02K | Hold |
100
| – | – | ﹤0.01% | 480 |
|
|
2023
Q2 | $753 | Hold |
100
| – | – | ﹤0.01% | 530 |
|
|
2023
Q1 | $885 | Hold |
100
| – | – | ﹤0.01% | 484 |
|
|
2022
Q4 | $912 | Hold |
100
| – | – | ﹤0.01% | 488 |
|
|
2022
Q3 | $1K | Sell |
100
-1,000
| -91% | -$10K | ﹤0.01% | 620 |
|
|
2022
Q2 | $8K | Hold |
1,100
| – | – | ﹤0.01% | 386 |
|
|
2022
Q1 | $10K | Hold |
1,100
| – | – | ﹤0.01% | 373 |
|
|
2021
Q4 | $9K | Hold |
1,100
| – | – | ﹤0.01% | 397 |
|
|
2021
Q3 | $11K | Hold |
1,100
| – | – | ﹤0.01% | 353 |
|
|
2021
Q2 | $11K | Hold |
1,100
| – | – | ﹤0.01% | 354 |
|
|
2021
Q1 | $13K | Hold |
1,100
| – | – | ﹤0.01% | 357 |
|
|
2020
Q4 | $11K | Buy |
1,100
+1,000
| +1,000% | +$10K | ﹤0.01% | 336 |
|
|
2020
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 432 |
|
|
2020
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 437 |
|
|
2020
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 556 |
|
|
2019
Q4 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 449 |
|